Marth C, Kirchebner P, Daxenbichler G
Department of Obstetrics and Gynecology, University Hospital, Innsbruck, Austria.
Cancer Lett. 1989 Jan;44(1):55-9. doi: 10.1016/0304-3835(89)90108-0.
Retinoic acid alone has no effect on the human breast cancer cell line BT-20 but can amplify the antiproliferative action of interferon-gamma (IFN-gamma). In our system ornithine decarboxylase (ODC) activity correlates well with growth rate; it was investigated whether the antiproliferative effects of IFN-gamma and IFN-gamma plus retinoic acid could be attributed to suppression of ODC activity. The ODC inhibitor difluoromethylornithine (DFMO), which is active as a single agent did not enhance growth inhibition induced by the biological response modifiers. The substitution of the BT-20 cells with putrescine, the product of the enzymatic reaction mediated by ODC, reversed DFMO induced antiproliferative action. On the other hand putrescine did not affect the proliferation of BT-20 cells treated with interferon alone or in combination with retinoic acid.
视黄酸单独对人乳腺癌细胞系BT - 20没有作用,但能增强γ干扰素(IFN - γ)的抗增殖作用。在我们的体系中,鸟氨酸脱羧酶(ODC)活性与生长速率密切相关;研究了IFN - γ以及IFN - γ加视黄酸的抗增殖作用是否可归因于ODC活性的抑制。ODC抑制剂二氟甲基鸟氨酸(DFMO)作为单一药物有活性,但并未增强生物反应调节剂诱导的生长抑制。用腐胺(ODC介导的酶促反应产物)替代BT - 20细胞,可逆转DFMO诱导的抗增殖作用。另一方面,腐胺并不影响单独用干扰素或与视黄酸联合处理的BT - 20细胞的增殖。